The Japan Medical Plastics Tubing Market was valued at $183.8 Million in 2026 and projected to reach to $253 Million by 2031, representing a compound annual growth rate of 6.6%. Japan's medical plastics tubing market is positioned for steady growth, driven by its aging population and advanced healthcare infrastructure.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Japan's rapidly aging demographic, with over 29% of the population aged 65+, significantly increases demand for medical tubing in chronic disease management, dialysis, and long-term care applications.
Japan's world-class healthcare system and high medical device adoption rates create a premium market for sophisticated, high-quality medical plastics tubing across hospitals, clinics, and home care settings.
Stringent Japanese regulatory requirements and PMDA approval processes ensure only premium-grade medical tubing enters the market, supporting higher-value product positioning and sustained quality demand.
Increasing adoption of minimally invasive surgical techniques and diagnostic procedures in Japan drives specialized demand for precision-engineered medical tubing in endoscopy, catheterization, and interventional applications.
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
Saint-Gobain manufactures a broad portfolio of medical-grade plastic tubing including thermoplastic elastomer (TPE), PVC, and silicone tubing used in IV infusion sets, peristaltic pump lines, and surgical drainage systems. | Their medical plastic tubing offers excellent chemical compatibility with common drug formulations, low extractables, and leachables profiles, consistent dimensional tolerances for leak-free connections, and kink resistance critical for uninterrupted fluid delivery in clinical settings. |
|
|
Freudenberg Medical specializes in extruded plastic and PEEK-based tubing for high-pressure fluid transfer applications, including contrast media delivery, balloon catheter inflation lumens, and implantable drug infusion systems. | Their plastic tubing solutions withstand high burst pressures without deformation, maintain dimensional stability across sterilization cycles including EtO and gamma irradiation, exhibit low protein adsorption for drug-contact lumens, and offer custom multi-lumen configurations that reduce device assembly complexity. |
|
|
Lubrizol provides engineered thermoplastic polyurethane (TPU) and Tecoflex-grade plastic tubing compounds specifically formulated for catheter tubing, hemodialysis blood lines, and minimally invasive surgical tubing. | Lubrizol's plastic tubing materials are inherently biocompatible and hemocompatible for blood-contacting applications, resistant to kinking and permanent deformation, bondable with standard medical adhesives, sterilization-compatible, and capable of being co-extruded with radiopaque fillers or drug-eluting compounds for advanced catheter functionality. |
|
|
W. L. Gore & Associates manufactures ePTFE and fluoropolymer-based plastic tubing used in bioprocessing fluid transfer lines, minimally invasive surgical tubing, and high-purity pharmaceutical fluid pathways. | Gore's plastic tubing provides exceptional resistance to a wide range of aggressive pharmaceutical solvents and sterilants, ultra-smooth inner bore surfaces that minimize particulate shedding and bacterial adhesion, stable flow performance under pressure fluctuations, and compliance with FDA 21 CFR and USP standards for use in drug manufacturing and delivery environments. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | BRAIDED TUBING (Structure) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 7.1% from 2026 to 2031 |
| Largest Segment | CATHETERS & CANNULAS (Application) |
| Market Size Base Year (Billions) | ~USD 4.83 (2026) |
| Revenue Forecast (Billions) | ~USD 6.81 (2031) |
| Segments Covered | Material, Structure, Application |
3 segment dimensions are covered across the global market.
Japan's medical plastics tubing market is valued at USD 183.8 million in 2026 and is expected to reach USD 253.0 million by 2031.
Japan's medical plastics tubing market is projected to grow at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2031.
Growth in Japan is driven by an aging population, advanced healthcare infrastructure, increasing minimally invasive procedures, and Japan's commitment to medical device innovation and quality standards.
Japan's medical plastics tubing market utilizes advanced materials including silicone and thermoplastic elastomers that meet Japan's rigorous biocompatibility and regulatory requirements.
Japan's stringent regulatory standards and emphasis on product quality and biocompatibility position the country as a premium market, supporting demand for high-performance medical tubing solutions.
The study involved four major activities to estimate the current size of the global medical plastics tubing market. Exhaustive secondary research was carried out to collect information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of medical plastics tubing through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the medical plastics tubing market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.
The market for companies offering medical plastics tubing was derived from secondary data available through paid and unpaid sources, by analyzing the product portfolios of the major companies in the ecosystem, and by rating the companies based on their performance and quality. Various secondary sources, such as Business Standard, Bloomberg, World Bank, and Factiva, were referred to identify and collect information for this study on the medical plastics tubing market. In the secondary research process, various secondary sources were referred to identify and collect information related to the study. Secondary sources included annual reports, press releases, and investor presentations of door vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.
In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the medical plastics tubing market. After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also conducted to identify the segmentation, industry trends, competitive landscape of medical plastics tubing offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

Notes: Other designations include sales, marketing, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
The top-down and bottom-up approaches were used to estimate and validate the size of the global medical plastics tubing market. These approaches were also used extensively to estimate the size of various dependent market segments. The research methodology used to estimate the market size included the following:

After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Medical plastics tubing refers to high-performance polymer tubes primarily used in medical devices and healthcare systems to transfer fluids, gases, or pharmaceutical products safely. To achieve optimal biological compatibility, flexibility, chemical resistance, and sterilizability, medical-grade polymers are used. The production techniques include accurate extrusion, co-extrusion, braiding, tapering, and other quality-controlled processes to produce tubing with very consistent dimensions and superior mechanical properties.
With the given market data, MarketsandMarkets offers customizations according to client-specific needs.
The following customization options are available for the medical plastics tubing market report:
Product Analysis
Regional Analysis
Company Information
Full forecast, segment splits, and company analysis for all Medical Plastics Tubing Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report